NACHT MARIUS 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-02 06:36 am Sale |
2023-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
NACHT MARIUS | 2,208,913 2.900% |
-607,988 (-21.58%) |
Filing |
| 2023-01-03 06:01 am Unchanged |
2022-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
NACHT MARIUS | 2,816,901 5.300% |
0 (Unchanged) |
Filing |
| 2022-01-31 07:16 am Sale |
2021-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
NACHT MARIUS | 2,816,901 5.800% |
-570,421 (-16.84%) |
Filing |
| 2021-02-08 06:08 am Purchase |
2020-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
NACHT MARIUS | 3,387,322 9.990% |
99,231 (+3.02%) |
Filing |
| 2020-11-24 06:04 am Purchase |
2020-03-18 | 13G | Protalix BioTherapeutics, Inc. PLX |
NACHT MARIUS | 3,288,091 9.900% |
3,288,091 (New Position) |
Filing |